O’Melveny has advised Hangzhou Diagens Biotechnology Co., Ltd. in its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. Hangzhou...
Diagens Completes HK$790 Million Initial Public Offering on Hong Kong Stock Exchange
Softcare Raises HK$2.38 Billion in Hong Kong IPO
Sidley and DLA Piper have advised Softcare. Herbert Smith Freehills Kramer has advised the underwriters. Softcare Limited (Softcare) has completed its initial public offering and listing...
TS Lines’ IPO on Hong Kong Stock Exchange
Herbert Smith Freehills advised joint sponsors on T.S. Lines’ Hong Kong IPO. T.S. Lines Limited (02510.HK) completed its listing on the Main Board of the Hong...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
Linmon Media Limited’s HK$420 Million Initial Public Offering
Harneys acted as Cayman Islands counsel to Linmon Media Limited on the matter. Clifford Chance provided Hong Kong and US legal advice and CM Law Firm...
JL MAG Rare-Earth Co., Ltd.’s Dual Primary Listing
Herbert Smith Freehills has advised JL MAG Rare-Earth Co., Ltd. on the deal. JL Mag produces high-performance NdFeB rare earth permanent magnets (REPMs), which are used...
Acotec Scientific Holdings Limited’s HK$1.529 Billion Hong Kong Initial Public Offering
Herbert Smith Freehills has advised Morgan Stanley and CICC on the matter while O’Melveny & Myers and Maples and Calder represented Acotec Scientific Holdings Limited. The...
Yuexiu Services’ HK$1.8 Billion Global Offering and Hong Kong Listing
King & Wood Mallesons advised Yuexiu Services on the spin-off and subsequent listing of its shares on the Main Board of The Stock Exchange of Hong...